08.03.2014 Views

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

When citing these abstracts please use the following reference:<br />

Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number.<br />

Please note that the official publication of the <strong>International</strong> Journal of <strong>Infectious</strong> Diseases 2010, Volume 14, Supplement 1<br />

is available electronically on http://www.sciencedirect.com<br />

Final Abstract Number: 78.020<br />

Session: HIV: Opportunistic Infections & Malignancies<br />

Date: Friday, March 12, 2010<br />

Time: 12:30-13:30<br />

Room: <strong>Poster</strong> & Exhibition Area/Ground Level<br />

Type: <strong>Poster</strong> Presentation<br />

Human Papillomavirus (HPV) detection in urine of HIV-infected women<br />

I. Rosa-Cunha, J. Prewitt, T. Guettouche, T. Hooton<br />

University of Miami, Miami, Fl, USA<br />

Background: HIV-infected women are at higher risk of cervical HPV infection persistence and<br />

related malignancy and the incidence of cervical cancer is likely to increase along with patient<br />

survival. The importance of screening in this population is thus evident, but costs of providing pap<br />

exams are considerable, the test is less than 70% sensitive, and nearly 1 in 4 HIV-infected<br />

women do not receive an annual Pap test. We assessed the feasibility of using urine samples<br />

from HIV-infected women to screen <strong>for</strong> HPV infection and cervical disease.<br />

Methods: 18 HIV-infected women referred to HIV colposcopy clinic at Jackson Memorial<br />

Hospital, Miami, Fl, <strong>for</strong> further evaluation of abnormal cervical Pap smear results agreed to collect<br />

urine sample <strong>for</strong> HPV testing. Colposcopy clinic practioners per<strong>for</strong>med colposcopic examination<br />

with biopsy of visible lesion(s) as per clinic routine. Participants self collected at least 15ml of<br />

urine. Presence of HPV in urine was evaluated using HPV Genotyping Microarray (Kurabo<br />

Industries Ltd, Osaka, Japan) with the capability to specifically identify 23 oncogenic HPV<br />

types.<br />

Results: 100% of the women approached accepted to participate in the study. Baseline cervical<br />

Pap smear results that triggered colposcopy referral were: 12 women (67%) with low grade<br />

squamous intraepithelial lesion and 6 (33%) with atypical cells of unknown significance (AS-<br />

CUS). Results <strong>for</strong> routine HPV testing using Hybrid Capture II assay (Digene Corp., Silver<br />

Spring, MD) were available <strong>for</strong> 12 participants with 9 samples (75%)being positive <strong>for</strong> HPV.<br />

Cervical biopsies were per<strong>for</strong>med in 16 of the 18 patients referred to colposcopy; 13 patients had<br />

cervical intraepithelial neoplasia (CIN) I, 2 had CIN II and 1 had no abnormality. Urine HPV<br />

testing was positive in all but two patients; 46% of the samples were positive <strong>for</strong> multiple HPV<br />

oncogenic types; most isolated oncogenic HPV (71%) were non-16 and non-18 types.<br />

Conclusion: Preliminary analysis suggests that self-collected urine sample <strong>for</strong> HPV testing was<br />

well accepted by HIV-infected women and could potentially have a role as a screening method <strong>for</strong><br />

HPV infection and cervical dysplasia in this population. More studies are needed to further<br />

evaluate the potential of urine HPV screening in HIV-infected women.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!